2026 NPPES data Internal Medicine Physician NPI 1235222506 M.D.
Verify on CMS →

JOHN FRAZIER, M.D.

Internal Medicine Physician in BRISTOL, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
423
Medicare Part D claims · 142 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$24.96
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOHN FRAZIER, M.D. filed 423 Medicare Part D claims in 2023 as a Internal Medicine Physician in BRISTOL, Connecticut, prescribing 85% generic.

423
Part D claims, 2023
85%
generic prescribing
$24.96
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN FRAZIER, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

423 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOHN FRAZIER, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN FRAZIER, M.D.?

Quality data not reported

NPI registry status

Active

Issued 10/01/2006

NPI 1235222506

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

423 84% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in Connecticut

How Internal Medicine Physician compares to other specialties among Connecticut providers

Connecticut providers

Internal Medicine Physician share within Connecticut

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN FRAZIER, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 123 MAPLE ST, BRISTOL, CT, 06010, with a listed phone of (860) 584-8021. NPI 1235222506 was issued on 10/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FRAZIER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 423 prescription claims written by this provider, covering 142 Medicare beneficiaries and totaling roughly $52K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

123 MAPLE ST
BRISTOL, CT 06010

Provider Details

NPI 1235222506
Specialty Internal Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 10/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOHN FRAZIER, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$25

Largest payer

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

JOHN FRAZIER, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 423 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

423
Total Claims
$52K
Total Drug Cost
142
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
852
Total Day Supply
25,290
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$38K
Generic Drug Cost
$14K

Patient Demographics

Average Patient Age
77.8 years
Avg HCC Risk Score
1.25
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOHN FRAZIER, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
48
Levothyroxine Sodium
30
Rosuvastatin Calcium
20
Albuterol Sulfate Hfa
Albuterol Sulfate
14
Amlodipine Besylate
14
Carvedilol
14
Hydrochlorothiazide
14
Trazodone Hcl
14
Venlafaxine Hcl Er
Venlafaxine Hcl
13
Ezetimibe
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How JOHN FRAZIER, M.D. fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

JOHN FRAZIER, M.D.'s 423 claims are below the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as FRAZIER.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN FRAZIER, M.D.'s specialty?
JOHN FRAZIER, M.D. specializes in Internal Medicine Physician and practices in BRISTOL, Connecticut. Credentials: M.D..
How much does JOHN FRAZIER, M.D. prescribe under Medicare Part D?
In 2023, JOHN FRAZIER, M.D. wrote 423 Medicare Part D claims totaling $52K in drug costs for 142 beneficiaries.
Where is JOHN FRAZIER, M.D. located?
JOHN FRAZIER, M.D. is located at 123 MAPLE ST, BRISTOL, CT, 06010. Phone: (860) 584-8021.
What is JOHN FRAZIER, M.D.'s NPI number?
JOHN FRAZIER, M.D.'s National Provider Identifier (NPI) is 1235222506, issued on 10/01/2006.
Does JOHN FRAZIER, M.D. prescribe more brand-name or generic drugs?
JOHN FRAZIER, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $38K in brand drug costs.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does JOHN FRAZIER, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN FRAZIER, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Levothyroxine Sodium, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN FRAZIER, M.D. accept Medicare?
JOHN FRAZIER, M.D. appears in CMS Medicare data with 423 Part D claims and 142 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN FRAZIER, M.D.'s credentials?
JOHN FRAZIER, M.D.'s NPI is 1235222506 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology